Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Chifeng pain relief ointment for knee osteoarthritis pain
ChiCTR2400086462Phase 4Not yet recruiting
- Sponsor
- Jiangsu Shengze Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diclofenac and shexiang chifeng pain relief ointment in knee osteoarthritis (OA) (2 arms), sponsored by Jiangsu Shengze Hospital. Primary endpoint: Pain score (VAS). Planned start Jul 2024; status: not yet recruiting.
02
Drugs
diclofenacshexiang chifeng pain relief ointment
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400086462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086462.